Prompt
You are a drug information pharmacist. Answer this question for a practicing pharmacist, not a patient.

Question: {{question}}
Setting and relevant de-identified context: {{context}}

Format:
1. Bottom line — 2-3 sentences, a direct answer with the strength of the evidence stated plainly.
2. What the evidence says — key findings, clearly distinguishing FDA labeling from practice guidelines from primary literature.
3. What I could not verify — anything you are uncertain about, stated explicitly.
4. Verify before acting — the exact items I should confirm in Lexicomp, Micromedex, or the package insert before this touches a patient.

Rules:
- If you are not certain a source exists, write "no citation available" — never fabricate a citation, author, or journal. I will check every reference you give.
- Tag every dose, interaction severity, and stability claim with [VERIFY] — those come from primary references, not from you.
- If the question cannot be answered without patient-specific data I did not provide, say what is missing instead of assuming.
- Under 400 words.

Fill in your details and the prompt updates live — then copy.

What you get back (excerpt)

Bottom line: Yes — calcium carbonate reduces levothyroxine absorption, and standard practice is to separate the doses by several hours [VERIFY: exact interval per Lexicomp]. This is a well-documented, manageable interaction, not a reason to stop either product. What the evidence says: FDA labeling for levothyroxine lists calcium carbonate among agents that decrease absorption and advises separating administration [VERIFY: labeling wording]. Small prospective studies showed reduced T4 levels with co-administration. What I could not verify: whether newer calcium salts differ meaningfully. Verify before acting: the recommended separation interval and any patient-specific absorption issues.

The full workflow

  1. Ask the question with setting and context, not just the drug names
  2. Check every [VERIFY] tag against Lexicomp, Micromedex, or the package insert
  3. Spot-check any citation the model offers — fabricated references are common
  4. Document your answer from the primary reference, not from the chat transcript

Watch out for

A chatbot is never a primary drug information reference. In published testing it missed a real Paxlovid-verapamil interaction and answered most medication questions unsatisfactorily — verify everything against Lexicomp, Micromedex, or the labeling.

Fabricated citations are the signature failure: studies found nearly half of AI-generated medical references do not exist. Check each one before it enters your documentation.

HIPAA: strip patient identifiers from the context — a de-identified scenario answers the question just as well.

Where this comes from

Every use case on this site is grounded in real reports from working pharmacists — not invented by us.

More AI use cases for pharmacists

← All 6 use cases: How Pharmacists Use AI